Enovis Price to Free Cash Flow Ratio 2010-2024 | ENOV
Enovis Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2025-05-15 | 35.73 | 0.00 | |
2024-12-31 | 43.88 | $-1.22 | 0.00 |
2024-09-30 | 43.05 | $-1.28 | 0.00 |
2024-06-30 | 45.20 | $-0.50 | 0.00 |
2024-03-31 | 62.45 | $-0.08 | 0.00 |
2023-12-31 | 56.02 | $0.83 | 67.34 |
2023-09-30 | 52.73 | $-1.08 | 0.00 |
2023-06-30 | 64.12 | $-1.97 | 0.00 |
2023-03-31 | 53.49 | $-2.69 | 0.00 |
2022-12-31 | 53.52 | $-2.93 | 0.00 |
2022-09-30 | 46.07 | $-0.09 | 0.00 |
2022-06-30 | 55.00 | $1.15 | 47.82 |
2022-03-31 | 68.44 | $3.13 | 21.85 |
2021-12-31 | 79.06 | $5.06 | 15.62 |
2021-09-30 | 78.94 | $5.79 | 13.64 |
2021-06-30 | 78.79 | $5.63 | 13.99 |
2021-03-31 | 75.35 | $5.01 | 15.03 |
2020-12-31 | 65.77 | $4.31 | 15.24 |
2020-09-30 | 53.94 | $2.98 | 18.08 |
2020-06-30 | 47.99 | $2.44 | 19.65 |
2020-03-31 | 34.05 | $3.00 | 11.35 |
2019-12-31 | 62.57 | $0.29 | 213.84 |
2019-09-30 | 49.98 | $2.18 | 22.93 |
2019-06-30 | 48.21 | $3.08 | 15.64 |
2019-03-31 | 51.05 | $2.73 | 18.68 |
2018-12-31 | 35.95 | $4.76 | 7.56 |
2018-09-30 | 62.02 | $3.85 | 16.10 |
2018-06-30 | 52.72 | $2.98 | 17.70 |
2018-03-31 | 54.87 | $3.33 | 16.46 |
2017-12-31 | 68.14 | $4.14 | 16.45 |
2017-09-30 | 71.62 | $5.46 | 13.12 |
2017-06-30 | 67.71 | $5.63 | 12.02 |
2017-03-31 | 67.52 | $5.34 | 12.64 |
2016-12-31 | 61.80 | $4.65 | 13.29 |
2016-09-30 | 54.06 | $4.22 | 12.80 |
2016-06-30 | 45.51 | $5.21 | 8.73 |
2016-03-31 | 49.17 | $5.94 | 8.28 |
2015-12-31 | 40.16 | $5.62 | 7.14 |
2015-09-30 | 51.44 | $6.83 | 7.54 |
2015-06-30 | 79.37 | $8.66 | 9.17 |
2015-03-31 | 82.09 | $9.15 | 8.98 |
2014-12-31 | 88.70 | $7.37 | 12.04 |
2014-09-30 | 97.98 | $8.56 | 11.44 |
2014-06-30 | 128.20 | $7.22 | 17.75 |
2014-03-31 | 122.68 | $7.59 | 16.17 |
2013-12-31 | 109.54 | $8.69 | 12.61 |
2013-09-30 | 97.16 | $8.09 | 12.01 |
2013-06-30 | 89.62 | $6.62 | 13.54 |
2013-03-31 | 80.04 | $6.70 | 11.95 |
2012-12-31 | 69.40 | $2.99 | 23.19 |
2012-09-30 | 63.07 | $-0.70 | 0.00 |
2012-06-30 | 47.42 | $-0.83 | 0.00 |
2012-03-31 | 60.61 | $-1.86 | 0.00 |
2011-12-31 | 48.98 | $2.95 | 16.60 |
2011-09-30 | 34.85 | $3.70 | 9.41 |
2011-06-30 | 42.65 | $3.38 | 12.62 |
2011-03-31 | 39.47 | $2.57 | 15.35 |
2010-12-31 | 31.66 | $3.40 | 9.31 |
2010-09-30 | 25.58 | $1.89 | 13.53 |
2010-06-30 | 17.90 | $2.61 | 6.86 |
2010-03-31 | 20.24 | $2.35 | 8.61 |
2009-12-31 | 20.71 | $1.93 | 10.71 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.069B | $2.108B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.096B | 54.00 |
Hims & Hers Health (HIMS) | United States | $13.681B | 142.14 |
Tempus AI (TEM) | United States | $11.156B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.596B | 71.81 |
IRhythm Technologies (IRTC) | United States | $4.484B | 0.00 |
Privia Health (PRVA) | United States | $2.963B | 202.50 |
Schrodinger (SDGR) | United States | $1.747B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.691B | 0.00 |
Phreesia (PHR) | United States | $1.537B | 0.00 |
Omnicell (OMCL) | United States | $1.346B | 23.74 |
Azenta (AZTA) | United States | $1.233B | 57.32 |
10x Genomics (TXG) | United States | $1.115B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
Talkspace (TALK) | United States | $0.517B | 154.50 |
Veradigm (MDRX) | United States | $0.455B | 0.00 |
Claritev (CTEV) | United States | $0.435B | 0.00 |
Standard BioTools (LAB) | United States | $0.406B | 0.00 |
TruBridge (TBRG) | United States | $0.372B | 825.00 |
Health Catalyst (HCAT) | United States | $0.291B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
Pulmonx (LUNG) | United States | $0.131B | 0.00 |
American Well (AMWL) | United States | $0.111B | 0.00 |
CareCloud (CCLD) | United States | $0.086B | 3.27 |
MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
Outset Medical (OM) | United States | $0.067B | 0.00 |
111 (YI) | China | $0.065B | 0.00 |
P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.011B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |